{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:46:05Z","timestamp":1790520365974,"version":"4.1.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1044,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1111\/j.1365-2230.2012.04438.x","type":"journal-article","created":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T04:46:52Z","timestamp":1350881212000},"page":"496-500","source":"Crossref","is-referenced-by-count":54,"title":["Anti-immunoglobulin E in the treatment of refractory atopic dermatitis"],"prefix":"10.1093","volume":"38","author":[{"given":"D. H.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Y.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. N.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. K.","family":"Mun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,10,22]]},"reference":[{"key":"10.1111\/j.1365-2230.2012.04438.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8561(03)00066-3","article-title":"Epidemiology of atopic dermatitis","volume":"22","author":"Schultz-Larsen","year":"2002","journal-title":"Immunol Allergy Clin North Am"},{"issue":"Suppl.","key":"10.1111\/j.1365-2230.2012.04438.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"S475","DOI":"10.1016\/j.jaci.2005.10.018","article-title":"Atopic dermatitis","volume":"117","author":"Boguniewicz","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2230.2012.04438.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5021\/ad.2010.22.2.125","article-title":"Atopic dermatitis","volume":"22","author":"Bieber","year":"2010","journal-title":"Ann Dermatol"},{"key":"10.1111\/j.1365-2230.2012.04438.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaci.2006.03.045","article-title":"Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology\/American Academy of Allergy, Asthma and Immunology\/PRACTALL Consensus Report","volume":"118","author":"Akdis","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2230.2012.04438.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaad.2005.12.045","article-title":"Efficacy of anti-IgE therapy in patients with atopic dermatitis","volume":"55","author":"Vigo","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2012.04438.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2005.02.014","article-title":"Failure of omalizumab for treatment of severe adult atopic dermatitis","volume":"53","author":"Krathen","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2012.04438.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2125.2009.03401.x","article-title":"Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma","volume":"68","author":"Lowe","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1365-2230.2012.04438.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jaci.2007.08.060","article-title":"Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels","volume":"120","author":"Belloni","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2230.2012.04438.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaad.2005.09.030","article-title":"Treatment of recalcitrant atopic dermatitis with omalizumab","volume":"54","author":"Lane","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2012.04438.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2133.1975.tb03028.x","article-title":"Atopic disease and serum immunoglobulin-E","volume":"92","author":"Jones","year":"1975","journal-title":"Br J Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2012.04438.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2012.04438.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:11:38Z","timestamp":1676365898000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/38\/5\/496\/6623088"}},"subtitle":["Anti-immunoglobulin E in the treatment of refractory AD"],"short-title":[],"issued":{"date-parts":[[2012,10,22]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2012.04438.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718024232.793466752","asserted-by":"object"}]},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10,22]]}}}